-
Hebei Provincial Drug Administration issued a document to abolish distance and area restrictions on pharmacies
Time of Update: 2021-08-27
According to the "Notice on Optimizing the Approval of the Establishment of Pharmacies" (hereinafter referred to as the "Notice") issued by the Hebei Provincial Drug Administration recently, it is necessary to continue to optimize the approval services for the establishment of pharmacies, and to cancel the requirements for the set distance and business area of pharmaceutical retail companies.
-
After the national smog, the market for anti-thrombotic varieties has changed dramatically!
Time of Update: 2021-08-27
In addition to the above-mentioned 6 companies that have production approvals for clopidogrel bisulfate tablets, in September 2019, after the "4+7" national expansion and centralized procurement, the manufacturers that obtained the 4th category of chemical drugs include Nanjing Zhengda Tianqing, Jiangsu Lianhuan, Hunan Dino, Boda Weiye and Chengdu Yuandong Biotech are also gradually entering the provincial centralized procurement platform.
-
Class 1 new drugs sold 10 billion yuan, innovative drug companies "attack" the 100 billion tumor drug market
Time of Update: 2021-08-27
According to data from Mi Nei. com, in 2020, the sales of terminal anti-tumor drugs in public medical institutions in China will exceed 100 billion yuan, a year-on-year increase of 9.
-
Nanjing Chia Tai Tianqing will win the first imitation of 4 blockbuster new products have been approved
Time of Update: 2021-08-27
A few days ago, the official website of the State Food and Drug Administration showed that Nanjing Zhengda Tianqing entered the administrative examination and approval stage with the imitation of three types of safinamide mesylate tablets, which is expected to fill the gap in the domestic market .
-
Is the doctor’s lounge going to be standardized?
Time of Update: 2021-08-27
In recent years, as society has paid more attention to the occupational health of medical staff, some hospitals have also begun to pay attention to the environment and conditions of doctors’ lounges and offices .
-
Top 20 pharmaceutical companies in revenue: Johnson & Johnson, Roche, Pfizer, Bayer...
Time of Update: 2021-08-27
5 billion US dollars in the first half of the year, it ranked third in the total revenue list.
However, in terms of performance, even if the revenue from the new crown vaccine in the first half of the year is excluded, Pfizer's remaining product revenue will also be 22.
-
New medical reform: 12 years of exploration, into the "deep water area"
Time of Update: 2021-08-27
6 billion yuan, the basic medical insurance system covering the whole people, the establishment of the National Medical Insurance Bureau, and the national promotion of the reform of the separation of medicines-in continuous progress, the new medical reform has gone through 12 years .
-
Official announcement: It is difficult for a large number of machinery companies to pay back, and the amount involved is about 300 million
Time of Update: 2021-08-27
The local medical insurance bureau issued a document on adjusting the centralized "purchasing payment settlement method" for medicines and medical consumables.
-
The cumulative number of new coronary cases worldwide exceeds 200 million. How to accelerate the research and development of new drugs?
Time of Update: 2021-08-26
The high-tech development report of the Chinese Academy of Sciences pointed out that in the process of new drug research, obtaining a lead compound with biological activity through compound activity screening is the material basis of innovative drug research [1] .
-
Yuandong Biomass Central Procurement Wins Bid Net Profit Soars 9 Major Class 1 New Drugs Brilliant
Time of Update: 2021-08-15
With the continuous growth of sales of its main products and the contribution of new increments from centralized procurement and bidding, the company achieved a net profit of 117 million yuan, a year-on-year increase of 36.
-
Carrying out popular science publicity, the national medical device safety publicity week is highly enthusiastic
Time of Update: 2021-08-15
Event Overview On July 19, 2021 "National Medical Device Safety Publicity Week" was launched in Beijing, with the theme of "Innovative Development of Safe Use of Devices".
-
FDA's 4 new drugs hit the Chinese market and are increasingly valued!
Time of Update: 2021-08-15
According to statistics from the US Food and Drug Administration (FDA), the FDA approved 4 innovative drugs in July 2021, all of which are new molecular entities . Since 2021, the US FDA has succes
-
Improve and implement the review and evaluation system to promote the high-quality development of public hospitals
Time of Update: 2021-08-14
In order to further improve the review and evaluation system of hospitals in China, guide hospitals to strengthen their own construction and management, promote the high-quality development of hospitals in China, and better meet the needs of the people for medical services, recently, it was sponsored by the Institute of Hospital Management of the National Health Commission and Nanchang University The “Sixth China Hospital Evaluation and High-quality Development Conference” hosted by the First Affiliated Hospital was held in Nanchang .
-
271 medicines passed the preliminary review of medical insurance adjustment
Time of Update: 2021-08-14
On July 30, the State Administration of Medicine issued the "Announcement on Publicizing Drugs and Information that Passed the Preliminary Formal Examination of the 2021 National Medical Insurance Drug Catalogue Adjustment", and 271 medicines passed the preliminary form examination (see the attached table at the end of the article for details) .
-
The latest performance announcement of multinational pharmaceutical companies: AstraZeneca, Pfizer, Roche...
Time of Update: 2021-08-14
Affected by the adjustment of the new crown pneumonia business and the growth of blockbuster drugs in different situations, in the first half of this year, the rankings of major multinational pharmaceutical companies ushered in a new round of reshuffle.
-
The Ministry of Commerce issued another report on the circulation of medicines: pharmaceutical retail companies led the way in growth!
Time of Update: 2021-08-14
Pharmaceutical Network, August 3 News On July 30, the official website of the Ministry of Commerce released the "Statistical Analysis Report on the Operation of the Pharmaceutical Circulation Industr
-
In the United States, opportunities and challenges coexist in the development of Chinese medicine
Time of Update: 2021-08-10
Medical Network News, June 29 As of January 1, 2018, 47 states in the United States and the District of Columbia have passed acupuncture laws, ensuring the legal use and development of Chinese medici
-
congratulate! China officially obtains malaria elimination certification
Time of Update: 2021-08-10
According to WHO's standards, a country or region has no local malaria cases for 3 consecutive years, and an effective malaria rapid detection and monitoring system is established, and a malaria prevention and control plan is formulated to obtain malaria elimination certification .
-
Pien Tze Huang is "difficult to find a grain"?
Time of Update: 2021-08-09
” A Moutai dealer in Guangzhou told the Guangzhou Daily omnimedia reporter: He did open the Pien Tze Huang experience hall, but they were all sold at a guide price of 590 yuan.
-
How does Pien Tze Huang respond to market price speculation and high raw material costs?
Time of Update: 2021-08-09
Recently, the market price of Pien Tze Huang has encountered capital speculation, and the single tablet sales price of some online e-commerce platforms even exceeds 1,000 yuan .
